Targeting Gastrointestinal Transport Proteins to Control Hyperphosphatemia in Chronic Kidney Disease Denis FouqueMarc VervloetMarkus Ketteler Leading Article Open access 18 July 2018 Pages: 1171 - 1186
Adult-Onset Still’s Disease: Molecular Pathophysiology and Therapeutic Advances Paolo SfrisoSara BindoliPaola Galozzi Leading Article 01 August 2018 Pages: 1187 - 1195
Metastatic Melanoma: Recent Therapeutic Progress and Future Perspectives Nausicaa MalissenJean-Jacques Grob Review Article 10 August 2018 Pages: 1197 - 1209
Treating Chronic Pain: An Overview of Clinical Studies Centered on the Buprenorphine Option Mellar P. DavisGavril PasternakBertrand Behm Review Article 26 July 2018 Pages: 1211 - 1228
Perioperative Use of Intravenous Lidocaine Marc BeaussierAlain DelbosLuc Mercadal Review Article 16 August 2018 Pages: 1229 - 1246
Alectinib: A Review in Advanced, ALK-Positive NSCLC Julia PaikSohita Dhillon Adis Drug Evaluation 20 July 2018 Pages: 1247 - 1257
Meropenem/Vaborbactam: A Review in Complicated Urinary Tract Infections Sohita Dhillon Adis Drug Evaluation Open access 20 August 2018 Pages: 1259 - 1270
Danoprevir: First Global Approval Anthony MarkhamSusan J. Keam AdisInsight Report 16 August 2018 Pages: 1271 - 1276
Encorafenib and Binimetinib: First Global Approvals Matt Shirley AdisInsight Report 16 August 2018 Pages: 1277 - 1284
Correction to: Andexanet Alfa: First Global Approval Young-A Heo Correction Open access 21 July 2018 Pages: 1285 - 1285
Correction to: Anlotinib: First Global Approval Yahiya Y. Syed Correction 06 August 2018 Pages: 1287 - 1287